ISB News

ISB Innovations: Ultrasound-Based Tumor Biopsies

John Chevillet is a postdoc in the Hood Lab at Institute for Systems Biology in Seattle.
Name:

John Chevillet, PhD

Lab:

Hood

Research:

I am trying to develop an ultrasound-based method to take a sample from a tumor, thus replacing needle biopsies. An ultrasound-based method would minimize complications, better diagnose cancers, and direct the use of targeted therapies for personalized medicine.

Wish List:

If I had $10,000, I could analyze the blood specimens we currently have for cancer dna to demonstrate what this method can tell us about the mutations driving a tumor. If I had $100,000, I could analyze a wide spectrum of molecules (DNA, RNA and protein) and start to define a biomarker signature panel that could be used as a foundation for a test more accurate than what we have now. If I had $1 million, I could partner with physicians and patients to test this method.

How you can help:

Watch this short video and click the button at the end of the video. Or donate now.

If you have questions about this project or would like to speak directly with our researchers, contact us.

 

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.